LivaNova

UK - LondonBiotechnology3 H-1B visas (FY2023)

Focus: LivaNova is a UK-based biotech company specializing in nerve stimulation therapy with a lean team of 1-50 employees. The company operates across cardiovascular, neurological, and sleep disorder indications with a diversified pipeline of implantable devices and neuromodulation therapies.

Unknown

Profile data last refreshed 4d ago · AI intelligence enriched 2w ago

Employees

1-50

Open Jobs

About LivaNova

AI assessmentNot Hiring

No open roles listed right now. Follow LivaNova to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

3 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

aura6000 THN System

Sleep Apnea Syndromes

N/A

Clinical Trials (1)

NCT01796925Targeted Hypoglossal Neurostimulation Study #2

N/A

Help build intelligence for LivaNova

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep expertise in nerve stimulation and neuromodulation—a cutting-edge therapeutic modality with clinical validation across epilepsy, depression, sleep apnea, and heart failure
Broad portfolio spanning 50+ clinical programs with 7 Phase 3 programs providing multiple near-term catalysts and expansion opportunities
100% H1B approval rate (3/3 in 2023) signals visa-friendly hiring culture and willingness to recruit specialized talent

Watch Out For

Extremely small team (1-50 employees) limits career ladder depth, mentorship, and functional specialization typical of larger biotech firms
No disclosed financials, revenue, or funding data raises transparency concerns and makes runway/stability assessment impossible
Only 2 active job openings suggest minimal near-term growth or hiring velocity despite large pipeline

Generated by Claude from LivaNova's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Hypoglossal Nerve Stimulation

Obstructive Sleep Apnea

N/A

Clinical Trials (1)

NCT04950894Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation

N/A

Kinesthetic stimulation

Obstructive Sleep Apnea Syndrome

N/A

Clinical Trials (1)

NCT02789748PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Sleep Apnea syndrOmes

N/A

aura6000 System

Sleep Apnea Syndromes

N/A

Clinical Trials (1)

NCT01532180Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

N/A

The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice

Sleep Apnea

N/A

Clinical Trials (1)

NCT02577445The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice

N/A

Vagal Nerve Simulation

Treatment Resistant Depression

N/A

Clinical Trials (1)

NCT03320304A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

N/A

Accelerometer Live-Streaming Tool

Epilepsy, Tonic-Clonic

N/A

Clinical Trials (1)

NCT04282681XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)

N/A

Cardiac Resynchronization Therapy -Defibrillator

Heart Failure

N/A

Clinical Trials (1)

NCT03127202Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation

N/A

Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

Epilepsy

N/A

Clinical Trials (1)

NCT01281293Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated

N/A

European Cardiac Resynchronisation Therapy Survey

Heart Failure

N/A

IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

Epilepsy

N/A

Clinical Trials (1)

NCT05975931IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

N/A

4D Cardiac CT Scan

Aortic-valve Replacement

N/A

SOMNOtouch device

Healthy

N/A

Clinical Trials (1)

NCT02650232Pilot Study to Evaluate the Somnotouch Device to Quantify Spontaneous Baroreflex Sensitivity

N/A

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Patients Implanted With a Pacemaker

N/A

Clinical Trials (1)

NCT00531037Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

N/A

INRatio monitor by Hemosense

Management of Anticoagulation

N/A

Clinical Trials (1)

NCT00703963Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care

N/A

STIMTAVI : Evolution of Atrioventricular Conduction Disorders After TAVI

Pacemaker Implantation

N/A

Clinical Trials (1)

NCT03338582STIMTAVI : Evolution of Atrioventricular Conduction Disorders After TAVI

N/A

Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Lo

Syncope

N/A

Clinical Trials (1)

NCT02253134Monitoring of Syncopes and/or Sustained Palpitations of Suspected Arrhythmic Origin With External Loop-Recorder (SpiderFLASH)

N/A

Optimization With SonR Method in the ClinicAl pRactice

CRT Patients

N/A

Clinical Trials (1)

NCT02250547Optimization With SonR Method in the ClinicAl pRactice

N/A

Microburst Stimulation

Epilepsies, Partial

N/A

Clinical Trials (1)

NCT03446664Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

N/A

Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

Ventricular Tachycardia

N/A

Clinical Trials (1)

NCT01169896Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

N/A

An Observational Study on the Sorin Group New Brady Leads XFine and Beflex

Pacing Leads Implantation

N/A

Clinical Trials (1)

NCT01168518An Observational Study on the Sorin Group New Brady Leads XFine and Beflex

N/A

Vagal nerve stimulation

Autoimmune Diseases

N/A

Clinical Trials (1)

NCT03953768VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

N/A

dual chamber pacemaker with SafeR algorithm

Sinus Node Dysfunction

N/A

Clinical Trials (1)

NCT02586480Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode

N/A

MEMO 3D ring

Mitral Valve Disease

N/A

Clinical Trials (1)

NCT01987635Assessment of Sustained Systolic-to-diastolic Flexibility of the Mitral Valve Annulus With the Sorin MEMO 3D Mitral Anuloplasty Ring

N/A

Mitroflow DL

Aortic Stenosis

N/A

Clinical Trials (1)

NCT02351726Mitroflow DL Post Approval Study- North America

N/A

Implantable Cardioverter Defibrillators - Improving Risk Stratification

Sudden Cardiac Death

N/A

biological heart valve prosthesis

Heart Valve Diseases

N/A

Kinesthetic stimulation

Sleep Apnea, Obstructive

N/A

Clinical Trials (1)

NCT03300037HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor

N/A

pacemaker diagnostic algorithm

Sleep Apnea

N/A

Clinical Trials (1)

NCT02751021Sleep Apnea Diagnosis Using a Novel Pacemaker Algorithm and Link With Aldosterone Plasma Level in Patients Presenting With Diastolic Dysfunction

N/A

aura6000 System

Obstructive Sleep Apnea

N/A

Clinical Trials (1)

NCT02263859Targeted Hypoglossal Neurostimulation Study #3

N/A

Vagus Nerve Stimulation

Treatment Resistant Depression (TRD)

N/A

Clinical Trials (1)

NCT05952674Treatment Resistant Depression and Vagus Nerve Stimulation

N/A

Vagus Nerve Stimulation

Congestive Heart Failure

N/A

Clinical Trials (1)

NCT03163030Autonomic Regulation Therapy in Heart Failure With Preserved Ejection Fraction

N/A

Echocardiogram/SonR

Heart Failure

N/A

Clinical Trials (1)

NCT01287234Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal

N/A

Vagus Nerve Stimulation Therapy

Epilepsy

N/A

Clinical Trials (1)

NCT02385526Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

N/A

Vagus Nerve Stimulation

Epilepsy

N/A

Clinical Trials (1)

NCT03529045Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

N/A

Quality improvement intervention

Cardiovascular Disease

N/A

Clinical Trials (1)

NCT00432536Redesigning Cardiac Surgery to Reduce Neurologic Injury

N/A

Vagus Nerve Stimulation

Treatment Resistant Depression

N/A

Clinical Trials (1)

NCT03887715A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

N/A

Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated

Epilepsy

N/A

Clinical Trials (1)

NCT04779814Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK.

N/A

Control

Heart Failure

N/A

Clinical Trials (1)

NCT01293526Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR

N/A

Echocardiography and SonR recording

Congestive Heart Failure

N/A

Clinical Trials (1)

NCT01066078Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)

N/A

ProGuardian

Epilepsy

N/A

Clinical Trials (1)

NCT01626599Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data

N/A

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will pr

Treatment Resistant Depression

N/A

Clinical Trials (1)

NCT04753385The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

N/A

"In-Clinic LVAT"

Heart Failure

N/A

Clinical Trials (1)

NCT03014180Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)

N/A

VITARIA System

Heart Failure

N/A

Clinical Trials (1)

NCT03425422ANTHEM-HFrEF Pivotal Study